What the FDA’s Recall Guidance Means for Cosmetics
Articles
High Stakes, High Risk: England Moves to Rein in Aesthetics
How Beauty Can Make Watertight Claims from Lab to Shelf
Beyond the Ban: Beauty’s Race to Build Human-Relevant Testing
Experts Answer: How Can Brands Prepare for China’s New Cosmetic Rules?
A Global Lens on EU Beauty Regulations
FDA Takes Another Step Away From Animal Testing
Kojic Acid Faces Regulatory Limits, Biotech Steps In
Hazardous or Safe? Unpacking the EU's Omnibus VI
Trump's Tariff War with Canada Is Coming for Beauty … Again
The Haves and Have-Nots (Yet): Inside BEMT’s First-Mover Advantage
DSM-Firmenich’s $33 Million Antitrust Settlement
Counterfeit Beauty Faces EU Crackdown
5.9 Billion Parcels Later, the EU Tightens Its Customs Rules
FDA Panel Backs Six Peptides in Another MAHA Win
The Sunbed War: Can Britain Regulate Away Skin Cancer?
Nigeria Joins Regional Push to End Raw Cocoa Exports
Can Independent Validation Strengthen Beauty Claims?